An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Ra Medical Systems to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Ra Medical Systems (AMEX: RMED) announced its participation in the virtual H.C. Wainwright 23rd Annual Global Investment Conference from September 13-15, 2021. Management will present details regarding their DABRA excimer laser, designed for treating vascular diseases, which has FDA clearance for treating chronic total occlusions in lower extremity vascular disease. The webcast of the presentation will be available on their website starting September 13 at 7:00 a.m. Eastern time.
Positive
None.
Negative
None.
CARLSBAD, Calif.--(BUSINESS WIRE)--
Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular diseases, announces that management will present at the virtual H.C. Wainwright 23rd Annual Global Investment Conference being held September 13-15, 2021. A webcast of the presentation will be available on the “News and Events” section of the company’s website beginning Monday, September 13 at 7:00 a.m. Eastern time.
About Ra Medical Systems
Ra Medical Systems commercializes the DABRA excimer laser and catheters for the treatment of vascular diseases. DABRA has been cleared by the FDA for crossing chronic total occlusions in patients with symptomatic infrainguinal lower extremity vascular disease and has an intended use for ablating a channel in occlusive peripheral vascular disease. In addition, DABRA has been granted CE mark clearance for the endovascular treatment of infrainguinal arteries via atherectomy and for crossing total occlusions. DABRA breaks down plaque to its fundamental chemistry, such as proteins, lipids and other chemical compounds, eliminating blockages by essentially dissolving them without generating potentially harmful particulates. DABRA excimer lasers and catheters are manufactured in a 32,000-square-foot facility located in Carlsbad, Calif. The vertically integrated facility is ISO 13485 certified and is licensed by the State of California to manufacture sterile, single-use catheters in clean room environments.
When is Ra Medical Systems presenting at the H.C. Wainwright Global Investment Conference?
Ra Medical Systems will present at the H.C. Wainwright 23rd Annual Global Investment Conference from September 13-15, 2021.
What is the DABRA excimer laser used for?
The DABRA excimer laser is used for treating vascular diseases, specifically for crossing chronic total occlusions and ablating channels in occlusive peripheral vascular disease.
How can I watch the Ra Medical Systems presentation?
The presentation can be watched via a webcast available on Ra Medical Systems' website starting September 13, 2021, at 7:00 a.m. Eastern time.
What clearances does the DABRA excimer laser have?
The DABRA excimer laser has FDA clearance for treating chronic total occlusions and CE mark clearance for atherectomy and total occlusion crossing.
Where is Ra Medical Systems located?
Ra Medical Systems is located in Carlsbad, California.
